Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher McKinney

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
The New England Journal of Medicine|April 3, 2026
CRISPR-Cas12a Gene Editing of <i>HBG1</i> and <i>HBG2</i> Promoters to Treat Sickle Cell DiseaseRabi Hanna, Haydar Frangoul, Luis Pineiro, et al.
NEJM Evidence|February 25, 2025
Haploidentical Bone Marrow Transplantation for Sickle Cell DiseaseAdetola A Kassim, Mark C Walters, Mary Eapen, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
The New England Journal of Medicine|April 3, 2026
CRISPR-Cas12a Gene Editing of <i>HBG1</i> and <i>HBG2</i> Promoters to Treat Sickle Cell DiseaseRabi Hanna, Haydar Frangoul, Luis Pineiro, et al.
NEJM Evidence|February 25, 2025
Haploidentical Bone Marrow Transplantation for Sickle Cell DiseaseAdetola A Kassim, Mark C Walters, Mary Eapen, et al.
Pageof 2